Valsartan And Hydrochlorothiazide
Product Images NDC 53002-1788

4 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 53002-1788). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (8a4aa4e5 Fcff 4ad5 A9bc Fc823fc6453d 01)

Image 1 (8a4aa4e5 Fcff 4ad5 A9bc Fc823fc6453d 01)
This image contains four line graphs showing the probability of achieving specific blood pressure targets at Week 8 for Valsartan and Hydrochlorothiazide, Valsartan USP, Valsartan, Hydrochlorothiazide, and placebo. Figures 1 and 3 depict probabilities for systolic blood pressure thresholds (<140 mmHg and <130 mmHg) across baseline systolic blood pressure. Figures 2 and 4 show probabilities for diastolic blood pressure thresholds (<90 mmHg and <80 mmHg) across baseline diastolic blood pressure.*
FDA Label Image

Image 2 (8a4aa4e5 Fcff 4ad5 A9bc Fc823fc6453d 02)

Image 2 (8a4aa4e5 Fcff 4ad5 A9bc Fc823fc6453d 02)
Chemical structure diagram of the active ingredient valsartan, showing its molecular configuration with labeled chemical bonds and groups. The image depicts the three-dimensional arrangement of atoms, including benzene rings and functional groups relevant to valsartan's structure.*
FDA Label Image

Image-3 (8a4aa4e5 Fcff 4ad5 A9bc Fc823fc6453d 03)

Image-3 (8a4aa4e5 Fcff 4ad5 A9bc Fc823fc6453d 03)
Chemical structure of the active ingredient shown in the Valsartan and Hydrochlorothiazide product by RPK Pharmaceuticals, Inc. The diagram depicts a molecular structure with a chlorinated aromatic ring and sulfonamide group.*
FDA Label Image

Label Image (Lbl530021788)

Label Image (Lbl530021788)
Packaging label for Valsartan and Hydrochlorothiazide 320-25 mg tablets by RPK Pharmaceuticals, Inc. The label states the dosage form as yellow caplet and package size of 90 tablets. Instructions note to take one tablet daily or as directed. The label includes fields for patient name, clinic information, prescription details, and barcode with product NDC 53002-1788.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.